Edition:
United States

Lannett Company Inc (LCI.N)

LCI.N on New York Stock Exchange

19.95USD
23 Jun 2017
Change (% chg)

$-0.05 (-0.25%)
Prev Close
$20.00
Open
$20.00
Day's High
$20.10
Day's Low
$19.55
Volume
119,090
Avg. Vol
138,547
52-wk High
$39.95
52-wk Low
$16.75

Latest Key Developments (Source: Significant Developments)

Lannett gets approval for hydrocodone bitartrate, acetaminophen tablets
Thursday, 22 Jun 2017 06:53am EDT 

June 22 (Reuters) - Lannett Company Inc ::Lannett receives approval for hydrocodone bitartrate and acetaminophen tablets USP, 5 mg/300 mg, 7.5 mg/300 mg and 10 mg/300 mg.Lannett Company Inc - "approval, combined with two other recently approved ANDAs, will benefit our fiscal 2018 revenues".  Full Article

Lannett gets approval for niacin extended-release tablets USP, 500 mg, 1000 mg
Monday, 19 Jun 2017 06:53am EDT 

June 19 (Reuters) - Lannett Company Inc ::Lannett receives approval for niacin extended-release tablets USP, 500 mg and 1000 mg.Lannett Company Inc - received approval from FDA of ANDA for niacin extended-release tablets USP, 500 mg and 1000 mg.  Full Article

Lannett announces approval for amantadine hydrochloride capsules USP, 100 mg
Friday, 16 Jun 2017 06:53am EDT 

June 16 (Reuters) - Lannett Company Inc ::Lannett announces approval for amantadine hydrochloride capsules USP, 100 mg.Lannett Company Inc - ‍expect to launch amantadine hydrochloride capsules USP, 100 mg​ in time for coming flu season.Lannett Company Inc - approval for amantadine hydrochloride capsules USP, 100 mg comes too late to benefit fiscal 2017.  Full Article

Lannett announces FDA approval for levocetirizine dihydrochloride oral solution, 2.5 mg/5 ml
Tuesday, 16 May 2017 06:52am EDT 

May 16 (Reuters) - Lannett Company Inc :Lannett announces approval for levocetirizine dihydrochloride oral solution, 2.5 mg/5 ml (0.5 mg/ml).Lannett says levocetirizine dihydrochloride oral solution will be manufactured in Carmel, New York by Silarx Pharmaceuticals.  Full Article

Lannett Company Inc files for potential mixed shelf size not disclosed
Friday, 12 May 2017 05:14pm EDT 

May 12 (Reuters) - Lannett Company Inc ::Lannett Company Inc files for potential mixed shelf; size not disclosed - sec filing.  Full Article

Lannett voluntarily pays down remaining $25 mln principal balance of revolving credit facility
Tuesday, 9 May 2017 06:53am EDT 

May 9 (Reuters) - Lannett Company Inc :Lannett voluntarily pays down remaining $25 million principal balance of revolving credit facility.Will save approximately $7.3 million in annualized cash interest expense, at current rates as result of paying down balance of facility.  Full Article

Lannett reports Q3 earnings per share $0.40
Tuesday, 2 May 2017 04:15pm EDT 

May 2 (Reuters) - Lannett Company Inc :Lannett reports fiscal 2017 third-quarter financial results.Q3 adjusted earnings per share $0.77.Q3 earnings per share $0.40.Q3 sales $165.7 million versus I/B/E/S view $170.5 million.Q3 earnings per share view $0.87 -- Thomson Reuters I/B/E/S.Lannett Company Inc says company expects its fiscal 2017 Q4 profitability on an adjusted basis to be similar with its fiscal 2017 Q3.  Full Article

Lannett voluntarily pays down additional $25 mln of revolving credit facility
Thursday, 30 Mar 2017 06:53am EDT 

Lannett Company Inc : Lannett voluntarily pays down additional $25 million of revolving credit facility .Lannett Co - $25 million payment, combined with $75 million payment made earlier in Jan, to save co about $5.5 million in annualized cash interest expense at current rates.  Full Article

Lannett Co says FDA agreed to delay submission deadline for Methylphenidate ER tablets
Wednesday, 22 Feb 2017 06:54am EST 

Lannett Company Inc : Lannett provides further update on methylphenidate er tablets . Lannett company inc- FDA agreed to delay submission deadline for Methylphenidate ER tablets . Lannett company-FDA suspended deadline to submit materials in support of its request for hearing to consider FDA's proposal co withdraw ANDA for Methylphenidate ER . Lannett co-FDA expected to discuss sufficiency of documents related to Methylphenidate ER tablets with co once documents are released .Lannett co-FDA expected to establish new dates for submission of materials in support of hearing request.  Full Article

Lannett's subsidiary to launch $50 mln expansion - SEC filing
Tuesday, 31 Jan 2017 08:51am EST 

Lannett Company Inc :Lannett Company Inc - Cody Laboratories, a wholly owned subsidiary of company, would be launching a $50 million expansion to its facilities - SEC filing.  Full Article

More From Around the Web

BRIEF-Lannett gets approval for hydrocodone bitartrate, acetaminophen tablets

* Lannett receives approval for hydrocodone bitartrate and acetaminophen tablets USP, 5 mg/300 mg, 7.5 mg/300 mg and 10 mg/300 mg